Evidence map›Paper›PMID 30286031›Full record

Observational studyShock (Augusta, Ga.)2019

Angiopoietin Level Trajectories in Toddlers With Severe Sepsis and Septic Shock and Their Effect on Capillary Endothelium.

Richard W Pierce, Veronika Shabanova, Michael Canarie, Mathew Pinto, Yong Sing da Silva, Vineet Bhandari, John S Giuliano

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Shock (Augusta, Ga.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. A hitchhiker's guide through the COVID-19 galaxy.Clinical immunology (Orlando, Fla.) · 2021
    Review
  8. Review
  9. Article
  10. Article
  11. What's New in Shock, March 2019?Shock (Augusta, Ga.) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Richard W PierceDepartment of Pediatrics, Yale University, New Haven, Connecticut.
Veronika ShabanovaDepartment of Pediatrics, Yale University, New Haven, Connecticut.
Michael CanarieDepartment of Pediatrics, Yale University, New Haven, Connecticut.
Mathew PintoMaria Fareri Children's Hospital, Westchester, New York.
Yong Sing da SilvaDepartment of Pediatrics, The Mount Sinai School of Medicine, New York City, New York.
Vineet BhandariDepartment of Pediatrics, Drexel University, Philadelphia, Pennsylvania.
John S GiulianoDepartment of Pediatrics, Yale University, New Haven, Connecticut.
Yale University · USDrexel University · USIcahn School of Medicine at Mount Sinai · USMaria Fareri Children's Hospital · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
PROTEINS OF THE ENDOTHELIAL CELL SURFACER01HL036003 · NHLBI · YALE UNIVERSITY · PI KLUGER, MARTIN S, POBER, JORDAN S · 1985 to 2015
$5.7M
YALE PEDIATRIC BASIC SCIENCE TRAINING PROGRAMT32HD068201 · NICHD · YALE UNIVERSITY · PI EGAN, MARIE E · 2011 to 2015
$1.3M
NCATS NIH HHS UL1 TR001863NCRR NIH HHS UL1 RR024139NHLBI NIH HHS R01 HL036003NICHD NIH HHS T32 HD068201
6 · The paper itself

Abstract

objectiveAngiopoietins are postulated diagnostic biomarkers in children and adults with severe sepsis and septic shock. The diagnostic value of angiopoietins in children less than 5 years old has not been established, nor has their effect on permeability in the capillary microvasculature. We aim to determine if levels of angiopoietin-1 or -2 (angpt-1, -2) are diagnostic for severe sepsis/shock in young children and whether they affect the permeability of cultured human dermal microvascular endothelial cells (HDMEC).

designProspective observational study of children < 5 years old. Patients were classified as non-systemic inflammatory response syndrome (SIRS), SIRS/sepsis and severe sepsis/septic shock.

settingTertiary care pediatric hospitals. PATIENTS: Critically ill children.

interventionsNone. MEASUREMENTS: Plasma angpt-1 and -2 levels were measured with enzyme-linked immunoassays. Expression of angpt-2 in endothelial cells was assessed with quantitative polymerase chain reaction. Permeability changes in cultured HDMECs were assessed with transendothelial electrical resistance measurements.

resultsAngpt-1 levels were significantly higher in younger children compared with levels found in previous study of older children across disease severity (all P < 0.001). Angpt-2 was significantly higher in this cohort with severe sepsis/septic shock compared with children without SIRS and SIRS/sepsis (all P < 0.003). Angpt-2/1 ratio was also elevated in children with severe sepsis/septic shock but an order of magnitude less than older children (P < 0.02, P = 0.002). Angpt-1 and -2 did not affect basal HDMEC permeability or modulate leak in isolation or in the presence of tumor necrosis factor (TNF).

conclusionsAngpt-2 levels and the angpt-2/1 ratio are appropriate diagnostic biomarkers of severe sepsis/septic shock in children less than 5 years old. Neither angpt-1 nor -2 affects basal HDMEC permeability alone or modulates TNF induced capillary leak.

Indexed as

Angiopoietin-1Angiopoietin-2CapillariesCapillary PermeabilityEndothelium, VascularShock, SepticAge FactorsChild, PreschoolFemaleHumansInfantMaleProspective StudiesSeverity of Illness IndexAngiopoietin-1Angiopoietin-2ANGPT1 protein, humanANGPT2 protein, human

Identifiers

PMID30286031
PMCPMC6375782
OpenAlexW2895509272

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.